Sunday, 5 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    Cummins India Limited Commemorates 30 Years of Listing on NSE
    04/10/2025
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    Black Box Partners with Wind River to Accelerate Edge and Cloud Innovation Globally
    04/10/2025
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    10 Icons Who Inspire Change: A Celebration of Vision, Commitment & Legacy
    03/10/2025
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
    03/10/2025
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to  Billion
    Feedzai Accelerates AI-led Financial Crime Prevention with New Investment Round that Grows Company’s Valuation to $2 Billion
    02/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  • july
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres

PRNW Agency
Last updated: 14/09/2025 4:31 AM
PRNW Agency
Share
3 Min Read
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres
SHARE
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres

Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories.

- Advertisement -

WOBURN, Mass., Sept. 8, 2025 /PRNewswire/ — Sirtex Medical (“Sirtex”), a leading manufacturer of minimally invasive interventional oncology solutions, today announced that it has received an expanded CE Mark approval for SIR-Spheres® Y-90 resin microspheres for the treatment of patients with liver cancer. With this expansion, eligibility now covers both primary and secondary liver metastases, increasing patient access to a well-established, targeted therapy.

- Advertisement -

“This milestone is about more than regulatory approval—it’s about giving hope and options back to patients facing some of the toughest cancer diagnoses,” said Matt Schmidt, CEO of Sirtex Medical. “By expanding access to SIR-Spheres®, we’re ensuring that more people can benefit from a well-tolerated therapy when they need it most.”

- Advertisement -

Radioembolization—also known as selective internal radiation therapy (SIRT)—delivers yttrium-90 directly to tumors via the hepatic artery, allowing for high-dose, targeted radiation aiming to minimize impact to surrounding healthy tissue.

- Advertisement -

“Y-90 radioembolization has long demonstrated clinical value in managing complex liver tumors,” said Prof. Dr. med. Jens Ricke, Director of the Clinic and Polyclinic of Radiology at the University Hospital Ludwig-Maximilians in Munich, Germany. “With this expanded CE Mark, more patients will have access to a therapy that can extend life, improve quality of life, and offer hope when other treatments may no longer be effective.”

- Advertisement -

The CE Mark expansion follows an extensive review of clinical data demonstrating the safety and effectiveness of SIR-Spheres® across diverse liver metastases. Together with the FDA’s recent approval of SIR-Spheres® Y-90 resin microspheres for the treatment of unresectable HCC in the United States, this milestone underscores the growing global recognition of SIR-Spheres® as a versatile, differentiated therapy and reinforces the Sirtex commitment to advancing liver-directed interventional oncology.

- Advertisement -

For more information and details on how to incorporate SIR-Spheres® into your practice, please contact Sirtex at info-use@sirtex.com.

- Advertisement -

About SIR-Spheres® in Europe
SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of:

- Advertisement -
  • Unresectable hepatocellular carcinoma (HCC), or
  • Unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy, or
  • Unresectable intrahepatic cholangiocarcinoma (iCCA), or
  • Hepatic metastases by neuroendocrine tumours (mNET), or
  • Other liver metastases

Caution: Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings and precautions.

- Advertisement -

About Sirtex
Sirtex Medical is a global healthcare company focused on advancing minimally invasive, liver-directed cancer and embolization therapies. With offices in the U.S., Australia, Europe, and Asia, Sirtex delivers innovative minimally invasive interventional oncology and embolization solutions to physicians and patients worldwide. For more information, visit www.sirtex.com.

- Advertisement -

APM-EMEA-009-07-25

- Advertisement -

Logo – https://mma.prnewswire.com/media/926923/Sirtex_Medical_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/sirtex-receives-expanded-ce-mark-approval-for-sir-spheres-y-90-resin-microspheres-302547825.html

- Advertisement -
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
Celebrating Every Parent: Godrej L’Affaire’s New Campaign Sparks a Call To #BeAPetParent
HTX 2025 Mid-Year Security Report: Upgrading a Multi-Layered Defense for a Safer Crypto Ecosystem
CisionOne Wins “Best Media Monitoring Solution” for Second Consecutive Year at 2025 MarTech Breakthrough Awards
Aeluma Announces Proposed Public Offering of Common Stock
TAGGED: foraccessacrossannouncedapprovalbroadenedcancercemarkedeuropeexpandedincreasesindicationinterventionalinvasiveleadinglivermanufacturermarkmassmedicalmicrospheresminimallynewsoncologypatientsreceivedreceivesresinseptsir-spheressirspheres®sirtexsolutionsterritoriestherapytodaytreatmentwoburny-90
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Pink Salt Trick Recipe to Weight Loss Trend 2025: An Analysis of Slumber Slim as a Science Informed Option
Tech

Pink Salt Trick Recipe to Weight Loss Trend 2025: An Analysis of Slumber Slim as a Science Informed Option

27/07/2025
KuCoin Ventures Announces Strategic Investment in Stable — The First Stablechain Powered by USDT
Business

KuCoin Ventures Announces Strategic Investment in Stable — The First Stablechain Powered by USDT

01/08/2025
Breaking New Ground at IFA: Zendure Enhances Its Home Energy Management System and Enters the Electric Mobility Market
Automobile

Breaking New Ground at IFA: Zendure Enhances Its Home Energy Management System and Enters the Electric Mobility Market

05/09/2025
OXIO Recognized with Frost & Sullivan’s 2025 Global Telecom-as-a-Service Transformational Innovation Leadership Recognition for Redefining Connectivity Through Cloud-Native Innovation
Entertainment

OXIO Recognized with Frost & Sullivan’s 2025 Global Telecom-as-a-Service Transformational Innovation Leadership Recognition for Redefining Connectivity Through Cloud-Native Innovation

31/07/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?